Open Access

Septic shock in older people: a prospective cohort study

  • Fabiano Pinheiro da Silva1Email author,
  • Fernando Godinho Zampieri1,
  • Denise Frediani Barbeiro1,
  • Hermes Vieira Barbeiro1,
  • Alessandra Carvalho Goulart1,
  • Francisco Torggler Filho1,
  • Irineu Tadeu Velasco1,
  • Luiz Monteiro da Cruz Neto1,
  • Heraldo Possolo de Souza1 and
  • Marcel Cerqueira César Machado1
Immunity & Ageing201310:21

https://doi.org/10.1186/1742-4933-10-21

Received: 16 January 2013

Accepted: 2 June 2013

Published: 6 June 2013

Abstract

Background

Septic shock is the first cause of death in Intensive Care Units. Despite experimental data showing increased inflammatory response of aged animals following infection, the current accepted hypothesis claims that aged patients are immunocompromised, when compared to young individuals.

Results

Here, we describe a prospective cohort study designed to analyze the immune profile of this population.

Conclusion

Older people are as immunocompetent as the young individual, regarding the cytokines, chemokines and growth factors response to devastating infection.

Keywords

AgeingSepsisInflammation

Background

Ageing is a growing field of medical research, since this process is strongly related with diseases such as atherosclerosis, Alzheimer’s Disease, type 2 diabetes and other main causes of death worldwide. Older age is associated with chronically elevated circulating levels of inflammatory markers, such as tumor necrosis factor (TNFα), IL-1β, IL-6 and C-reactive protein (CRP) [1]. Immunosenescence seems to influence many components of the immune system. Profound changes in T cell function have been described in older individuals [2, 3], especially in Th17 and regulatory T cells activity [2, 4]. Regarding innate immunity, age-associated alterations have been described in macrophages, natural-killer and polymorphonuclear cells [5, 6]. Discrepant results, however, are frequently observed [7]. While some authors have detected an increase in cytokine production [8], for example, others have described opposing results [9].

Sepsis is a disease of older people. Indeed, 60% of all sepsis events and 80% of septic deaths occur in individuals over 65 years-old [10]. The incidence increases exponentially with age and older age is an independent risk factor for mortality among adults hospitalized with sepsis [11]. A recent prospective cohort study of patients hospitalized with pneumonia-induced sepsis found an age-related increase in in-hospital, 90-day and 1-year post-discharge mortality [12].

The reason for the higher susceptibility to infection and the higher risk of severe sepsis and mortality in older adults, however, remain unclear [13]. Here, we investigate the cytokine profile of aged individuals compared to young adults, during the development of overwhelming infection, in order to characterize the immune status of this population.

Results

We included 73 patients in this study protocol (44 patients admitted in the ICU for non-infectious reasons and 29 admitted for septic shock) between October 2010 and October 2012. In our study, patients in the ICU control and septic shock groups showed similar profile when young and aged patients were compared. Sex distribution was similar in both groups. Regarding the population characteristics (Table 1), elderly patients in the septic shock group showed worst renal function than young patients in the same group (p = 0.017), as accessed by creatinin plasma levels. Both young and aged patients showed similar sodium, potassium, magnesium, phosphate and chloride plasma levels, whether in the ICU or septic shock group. Calcium, a marker of severity of disease [14], was significantly lower in aged septic individuals than in aged controls (p = 0.043), but not than in young septic patients (p = 0.294). Hemoglobin (Hb) and hematocrit (Ht) levels significantly decreased in young septic patients compared to controls, but not in aged patients. Leukocytes and polymorponuclear cells (PMNs) significantly rose in young septic group compared to controls, but not in the elderly group. Platelets levels were similar in all study groups. Albumin significantly decreased in septic shock when compared to ICU controls, but young and aged patients showed similar albumin levels (p = 0.708). Lactate significantly rose in young, but not in the elderly, when patients in septic shock were compared to controls. The same profile was found for C-reactive protein levels. SOFA score and mortality were similar for the young and the older age septic groups (p = 0.517 and 0.986).
Table 1

Population characteristics

 

Young

Elderly

Group A vs. B

Control n=36

Septic shock (group A) n=21

p-value

Control n=8

Septic shock (group B) n=8

p-value

p-value

age (yrs)

45 ± 11

40 ± 13

0.154

73 ± 6

75 ± 9

0.666

0.000

male sex

38%

50

0.454

50

62%

0.766

 

creatinin (mg/dl)

1.50 ± 2.73

1.04 ± 1.24

0.523

1.50 ± 1.60

2.62 ± 1.40

0.173

0.017

sodium (meq/dl)

142 ± 11

139 ± 9

0.133

141 ± 6

146 ± 18

0.454

0.283

potassium (meq/dl)

3.52 ± 0.84

3.52 ± 1.16

0.988

3.62 ± 0.74

4.25 ± 0.70

0.122

0.055

magnesium (mg/dl)

1.44 ± 0.55

1.19 ± 0.51

0.147

1.38 ± 0.51

1.63 ± 0.51

0.302

0.064

calcium (mg/dl)

4.77 ± 0.86

4.42 ± 0.74

0.100

4.75 ± 0.46

4.12 ± 0.64

0.043

0.294

phosphate (mg/dl)

3.03 ± 1.15

3.86 ± 2.47

0.073

3.75 ± 1.66

4.38 ± 1.92

0.482

0.577

chloride (mg/dl)

107 ± 12

105 ± 7

0.527

108 ± 10

104 ± 6

0.394

0.703

hemoglobin (g/dl)

12 ± 2.0

10 ± 2.2

0.011

10 ± 2.0

10 ± 2.2

0.913

0.939

hematocrit (g/dl)

36 ± 6

30 ± 6

0.010

31 ± 6

32 ± 6

1.000

0.769

leucocytes (/mm3)

10891 ± 4386

15569 ± 13341

0.046

17830 ± 23033

11863 ± 6020

0.499

0.314

PMN cells (/mm3)

8778 ± 4003

12406 ± 10710

0.061

7518 ± 3917

10446 ± 5632

0.231

0.529

platelets (/mm3)

235833 ± 136039

224571 ± 171250

0.769

196500 ± 86663

152750 ± 69134

0.267

0.119

albumin (g/dl)

2.83 ± 0.81

2.04 ± 0.74

0.000

2.62 ± 0.51

2.12 ± 0.35

0.039

0.708

lactate (g/dl)

12.75 ± 6.83

31.61 ± 35.91

0.001

11.25 ± 4.71

19.12 ± 9.32

0.311

0.154

CRP (g/dl)

50 ± 76

139 ± 129

0.003

56 ± 73

96 ± 162

0.494

0.939

SOFA score

3.50 ± 3.12

9.14 ± 4.13

0.000

4.13 ± 3.22

9.25 ± 2.96

0.002

0.517

ICU mortality

11%

47%

0.003

37.5%

50%

0.628

0.939

Cytokines profile showed activation of innate immunity and polyclonal activation of T cells in the young during septic shock, characterized by a rise in TNFα, IL-1β, IL-6, IL-4, IL-17 and interferon-γ when compared to the ICU control group. No differences, however, could be detected when the young in septic shock (group A) was compared to the elderly in septic shock (group B) (Table 2). Chemokines and growth factors also showed similar values when the elderly was compared to young subjects (Table 3).
Table 2

Cytokines profile

 

Young

Elderly

Group A vs. B

Control n=36

Septic shock (group A) n=21

p-value

Control n=8

Septic shock (group B) n=8

p-value

p-value

IL-1α

31 ± 42

100 ± 82

0.000

27 ± 27

75 ± 82

0.270

0.242

IL-1β

2.50 ± 2.93

7.09 ± 7.11

0.007

1.12 ± 1.35

4.37 ± 6.98

0.480

0.148

IL-1 RA

36 ± 47

192 ± 295

0.001

31 ± 33

145 ± 292

0.114

0.317

IL-2

9.00 ± 6.74

13 ± 10

0.121

4.12 ± 2.10

9.62 ± 5.52

0.023

0.508

IL-3

2.08 ± 2.44

2.61 ± 3.33

0.849

0.62 ± 0.51

2.25 ± 2.54

0.070

0.899

IL-4

8.55 ± 10.60

32 ± 48

0.007

3.87 ± 4.91

16.00 ± 22.35

0.093

0.334

IL-5

2.19 ± 3.24

7.19 ± 9.26

0.010

0.50 ± 1.06

2.87 ± 3.44

0.082

0.208

IL-6

37 ± 63

1641 ± 3195

0.000

32 ± 39

1666 ± 3590

0.036

0.884

IL-7

11 ± 8.26

40 ± 39

0.000

5.62 ± 3.46

34.75 ± 48.70

0.002

0.393

IL-8

29 ± 25

806 ± 2819

0.000

26.25 ± 22.24

1695 ± 4602

0.016

0.354

IL-9

2.08 ± 2.37

4.52 ± 5.06

0.044

0.50 ± 1.06

4.25 ± 6.11

0.043

0.489

IL-10

12 ± 16

626 ± 2195

0.000

38 ± 78

480 ± 1079

0.012

0.575

IL-12p40

39 ± 44

111 ± 80

0.000

31 ± 34

141 ± 214

0.206

0.464

IL-12p70

7.19 ± 4.79

20.61 ± 20.09

0.002

4.50 ± 2.72

10.50 ± 8.79

0.423

0.195

IL-13

4.86 ± 6.51

14.90 ± 32.48

0.119

1.37 ± 1.06

10.87 ± 16.12

0.097

0.583

IL-15

7.38 ± 6.23

20.52 ± 25.30

0.001

4.00 ± 3.20

16.62 ± 18.92

0.011

0.558

IL-17

2.88 ± 2.43

8.66 ± 6.31

0.000

1.87 ± 1.45

6.87 ± 5.46

0.018

0.493

IFNα

67 ± 42

110 ± 58

0.000

195 ± 402

78 ± 38

0.270

0.150

IFNy

7.83 ± 4.45

40.09 ± 52.41

0.000

6.25 ± 5.67

30.87 ± 36.56

0.013

0.574

TFNα

19 ± 21

111 ± 207

0.000

23 ± 20

81 ± 102

0.016

0.770

Table 3

Chemokines and growth factors profile

 

Young

Elderly

Group A vs. B

Control n=36

Septic shock (group A) n=21

p-value

Control n=8

Septic shock (group B) n=8

p-value

p-value

EGF

266 ± 212

212 ± 182

0.264

192 ± 80

250 ± 213

0.600

0.696

FGF2

122 ± 62

133 ± 55

0.301

113 ± 45

153 ± 67

0.344

0.575

FITL3

6.27 ± 11.4

18 ± 165

0.000

6.25 ± 14.04

16 ± 27

0.235

0.104

FRAKTALINE

167 ± 81

573 ± 858

0.001

120 ± 73

296 ± 273

0.027

0.251

GCSF

156 ± 196

3662 ± 7100

0.001

104 ± 106

3226 ± 7166

0.093

0.922

GMCSF

32 ± 21

125 ± 284

0.000

48 ± 65

54 ± 43

0.208

0.241

GRO

1958 ± 1642

2644 ± 3934

0.772

1733 ± 884

4074 ± 4718

0.753

0.435

MCP-1

610 ± 912

2806 ± 4334

0.002

916 ± 1129

3237 ± 4792

0.171

1.0

MCP-3

24 ± 13

58 ± 44

0.001

11.62 ± 5.20

32 ± 25

0.023

0.130

MDC

817 ± 719

714 ± 471

0.869

745 ± 350

625 ± 265

0.208

0.527

MIP-1

23 ± 22

50 ± 65

0.069

322 ± 871

39 ± 25

0.127

0.696

MIP-1

42 ± 25

102 ± 83

0.000

35 ± 31

94 ± 60

0.027

0.678

VEGF

227 ± 306

310 ± 239

0.003

143 ± 115

392 ± 387

0.021

0.678

Discussion

Older age has been widely characterized as a pro-inflammatory state [15]. Animal models of infection also support that older subjects have higher circulating levels of inflammatory markers. Tateda et al. have shown that aged mice exhibit higher TNFα, IL-1β and IL-6 levels than young mice after intraperitoneal injection of LPS [16]. Using the cecal ligation and puncture model (CLP), Turnbull et al. also found similar results [17]. The underlying mechanism of the vulnerability to infections of the elderly has been ascribed to the breakdown of anatomic barriers, underlying illnesses or the declining capacity of the immune system [18], while latent infections such as cytomegalovirus (CMV) may act as chronic stimuli of the inflammatory system [19, 20]. Persistent inflammation has been shown to increase the risk of bacterial invasion in rodents by reducing neutrophil recruitment and bacterial clearance [21, 22]. Turnbull et al. proposed that macrophages of aged mice may be relatively activated, or primed, for cytokine production prior to LPS challenge. There have been, however, several conflicting reports, when in vitro production of cytokines by aged cells is investigated [2326]. In our study, we were also unable to find any cytokine, chemokine or growth factor that could serve to better explain the reasons why this population shows increased susceptibility and mortality to septic shock. Our results show, moreover, that leukocytosis, CRP and lactate are good markers of infection to young patients, but not to the aged one. We suggest that the increased mortality of the elderly described by others may underlie on the function of non-immune cells. Disruption of epithelial barriers, malfunction of ciliary cells, malabsorption, malnutrition, polimorphisms, deficits of cognition and associated comorbities, in our opinion, may play a pivotal role. Interestingly, impaired sympathetic response has been observed as a partial explanation for several modifications that occur during ageing [27], including increased mortality in septic shock [28].

Sepsis has challenged the medical community for decades. After the negative results of innumerous clinical trials, when researchers insisted that the disease could be controlled by inhibition of the pro-inflammatory response, a new hypothesis emerged. In 1996, Roger Bone proposed that early after the explosive inflammatory response that characterizes sepsis, a compensatory antagonistic response syndrome (CARS) would arise [29], explaining why anti-inflammatory drugs do not benefit septic patients and even further increase mortality. It is important to state that our study looks at the immune profile at one point in time. It is possible that immune profiles diverge later in disease. This point is important later when we talk about CARS, since CARS may still exist later in the disease course.

Actually, sepsis is considered a heterogenic disease, being very difficult to reproduce in animal models. Indeed, at the present time most of the researchers believe that a systemic inflammatory response syndrome (SIRS) prevails in young patients, while CARS dominates most of the septic inflammatory response of older people. In aged patients, thus, sepsis would be characterized by a dominant anti-inflammatory response, an immunocompromissed state [30]. Clinical trials, however, have not confirmed this hypothesis yet. Our study points out that the elderly has an efficient immune profile, very similar to the young patient.

Our study has limitations. The major limitation is the sample size. A recent clinical study, however, was unable to find any age-related difference in inflammatory and cell surface markers in patients hospitalized for pneumonia [12]. Similarly, Kelly et al. found no differences in the cytokine profile of young, older and very elderly patient with community-acquired pneumonia [31]. We believe that our data brings important information and should be further explored in larger studies. Once confirmed, studies of immunosenescence should focus on defects in phagocytosis, production of reactive oxygen species, immunoglobulins and other cell functions that were not addressed by the present study.

Conclusions

Our study describes that aged individuals display a competent immune profile, regarding the secretion of cytokines, chemokines and growth factors. Further research is warranted to explain the molecular mechanisms why aged individuals develop higher rates of infection and might display worse outcomes, a relevant topic on immune-inflammatory responses in ageing. Here, we point out that the results in animal models diverge from clinical research and argue against the current concept that sepsis in older people is characterized by CARS, a massive counter-antagonistic response to systemic inflammation. Larger studies are necessary to confirm our data and explore other aspects of immunity in this population.

Methods

Study design

The current study was a prospective cohort, conducted in one of the Hospital das Clinicas Intensive Care Units (University of Sao Paulo, Brazil). Surgical patients, trauma and coronary syndromes are usually admitted at other ICUs from our hospital, what makes our population very homogeneous. Indeed, the five following reasons account for more than 90% of the ICU admissions included in this study: sepsis, stroke, altered level of consciousness, pulmonary edema and asthma/COPD. Patients less than 18 years old, pregnant, with disseminated malignancies or receiving chemotherapy, HIV-positive, advanced hepatic disease, in end-of-life conditions and those that refused to participate in this study were excluded. The remaining patients were divided in two groups: 1) ICU control (patients admitted to the ICU for non-infectious causes); 2) septic shock group (patients admitted to the ICU for septic shock or that developed septic shock during the ICU stay). 90% of data from septic elderly were taken on hospital day 1 compared to 90% from elderly controls. Each group was divided in two sub-groups: under 65 years-old (young individuals) and above 65 years-old (aged individuals). Data and blood samples were collected at patient’s admission or when the diagnosis of severe sepsis or septic shock was established by the medical staff. SIRS, Severe sepsis and septic shock were defined, according to the consensus proposed in 1992 [32]. The protocol was approved by Hospital das Clinicas Ethical Committee and patients (or their close relatives) received detailed explanations and provided written consent to be included in the study protocol.

Statistical analysis

A descriptive analysis of the population (age, sex, electrolytes, SOFA score and mortality) was performed. SOFA score assesses mortality in the critically ill. Cytokines were analyzed by Miliplex technology (Merck, Genese diagnostics), a multiplex method for cytokines analysis. Continuous variables were analyzed by using Student’s t test or Mann–Whitney test, as appropriated. Categorical variables were analyzed by using chi-square test. Results were reported as mean ± standard deviation. All analysis performed used SPSS 19.0 software. A p value of .05 was considered to be statistically significant.

Declarations

Acknowledgements

The current study is part of an ongoing prospective cohort study, designed to store clinical data and biological samples for multiple projects and conceived by HPS and LMCN (Brazilian Initiative for Sepsis Knowledge, BRISK Project).

FPS is supported by FAPESP, São Paulo Research Foundation (grant # 2009/17731-2).

We would like to express our gratitude to the patients and their families for consenting to participate in this study.

Authors’ Affiliations

(1)
Emergency Medicine Department,, University of São Paulo,

References

  1. Bruunsgaard H, Pedersen M, Pedersen BK: Aging and proinflammatory cytokines. Curr Opin Hematol. 2001, 8 (3): 131-6. 10.1097/00062752-200105000-00001.View ArticlePubMedGoogle Scholar
  2. Haynes L, Maue AC: Effects of aging on T cell function. Curr Opin Immunol. 2009, 21 (4): 414-7. 10.1016/j.coi.2009.05.009.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Maue AC, Haynes L: CD4+T Cells and Immunosenescence - A Mini-Review. Gerontology. 2009, 55 (5): 491-495. 10.1159/000214842.View ArticlePubMedGoogle Scholar
  4. Maue AC: T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 2009, 30 (7): 301-5. 10.1016/j.it.2009.04.007.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Pawelec G: Impact of aging on innate immunity. J Leukoc Biol. 1998, 64 (6): 703-12.PubMedGoogle Scholar
  6. Shaw AC: Aging of the innate immune system. Curr Opin Immunol. 2010, 22 (4): 507-13. 10.1016/j.coi.2010.05.003.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Panda A: Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009, 30 (7): 325-33. 10.1016/j.it.2009.05.004.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Han D: Age-related enhancement of tumor necrosis factor (TNF) production in mice. Mech Ageing Dev. 1995, 84 (1): 39-54. 10.1016/0047-6374(95)01634-C.View ArticlePubMedGoogle Scholar
  9. Effros RB, Svoboda K, Walford RL: Influence of age and caloric restriction on macrophage IL-6 and TNF production. Lymphokine Cytokine Res. 1991, 10 (5): 347-51.PubMedGoogle Scholar
  10. Angus DC: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29 (7): 1303-10. 10.1097/00003246-200107000-00002.View ArticlePubMedGoogle Scholar
  11. Kale SS, Yende S: Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness. Aging Dis. 2011, 2 (6): 501-11.PubMed CentralPubMedGoogle Scholar
  12. Kale S: The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS One. 2010, 5 (11): e13852-10.1371/journal.pone.0013852.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Martin GS, Mannino DM, Moss M: The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006, 34 (1): 15-21. 10.1097/01.CCM.0000194535.82812.BA.View ArticlePubMedGoogle Scholar
  14. Pinheiro da Silva F: Decreased Parathyroid hormone levels despite persistent hypocalcemia in patients with kidney failure recovering from septic shock. Endocr Metab Immune Disord Drug Targets. 2012, in pressGoogle Scholar
  15. Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol. 2004, 39 (5): 687-99. 10.1016/j.exger.2004.01.009.View ArticlePubMedGoogle Scholar
  16. Tateda K: Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect Immun. 1996, 64 (3): 769-74.PubMed CentralPubMedGoogle Scholar
  17. Turnbull IR: Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock. 2003, 19 (4): 310-3. 10.1097/00024382-200304000-00003.View ArticlePubMedGoogle Scholar
  18. Gardner ID: The effect of aging on susceptibility to infection. Rev Infect Dis. 1980, 2 (5): 801-10. 10.1093/clinids/2.5.801.View ArticlePubMedGoogle Scholar
  19. Almanzar G: Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol. 2005, 79 (6): 3675-83. 10.1128/JVI.79.6.3675-3683.2005.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Schmaltz HN: Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc. 2005, 53 (5): 747-54. 10.1111/j.1532-5415.2005.53250.x.View ArticlePubMedGoogle Scholar
  21. White JC: Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection. J Infect Dis. 1986, 153 (2): 202-8. 10.1093/infdis/153.2.202.View ArticlePubMedGoogle Scholar
  22. Mason CM: Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms. J Infect Dis. 1997, 176 (5): 1293-302. 10.1086/514125.View ArticlePubMedGoogle Scholar
  23. Bradley SF: Monokine secretion in aging and protein malnutrition. J Leukoc Biol. 1989, 45 (6): 510-4.PubMedGoogle Scholar
  24. Bruley-Rosset M, Vergnon I: Interleukin-1 synthesis and activity in aged mice. Mech Ageing Dev. 1984, 24 (3): 247-64. 10.1016/0047-6374(84)90111-8.View ArticlePubMedGoogle Scholar
  25. Ershler WB: Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 1993, 12 (4): 225-30.PubMedGoogle Scholar
  26. Fagiolo U: Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993, 23 (9): 2375-8. 10.1002/eji.1830230950.View ArticlePubMedGoogle Scholar
  27. Santulli G, Iaccarino G: Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun Ageing. 2013, 10 (1): 10-10.1186/1742-4933-10-10.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Nakada TA: beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Respir Crit Care Med. 2010, 181 (2): 143-9. 10.1164/rccm.200903-0332OC.View ArticlePubMedGoogle Scholar
  29. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996, 24 (7): 1125-8. 10.1097/00003246-199607000-00010.View ArticlePubMedGoogle Scholar
  30. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 2003, 348 (2): 138-50. 10.1056/NEJMra021333.View ArticlePubMedGoogle Scholar
  31. Kelly E: Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?. Respirology. 2009, 14 (2): 210-6. 10.1111/j.1440-1843.2008.01423.x.View ArticlePubMedGoogle Scholar
  32. Bone RC: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992, 101 (6): 1644-55. 10.1378/chest.101.6.1644.View ArticlePubMedGoogle Scholar

Copyright

© Pinheiro da Silva et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement